drugset / Trial / NCT03642964
A Study in Patients With Major Depressive Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase 2a, placebo-controlled, single-blind study in up to 24 patients with major depressive disorder (MDD).
Timeline
- Start
- 2018-09-10
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramipexole | Unknown | — | Oral |
| Background | Ondansetron | Other / unclassified | 8 mg | Oral |